Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Vanda Pharmaceuticals Inc.

NASDAQ: VNDA · Life Sciences · 3 alerts · CIK 1347178

Share price
$3.81Close, Nov 16
Market cap
$230M
Shares outstanding
60.47MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Vanda Pharmaceuticals Inc. filings on SEC EDGAR ↗

4:17 PM ET Form 4
Insider Buying

Vanda Pharmaceuticals Director Charles Cliff Duncan Buys $35.2K of Stock

Charles Cliff Duncan, Director, bought 9,250 shares of Vanda Pharmaceuticals Inc. at $3.80 to $3.82 a share (average $3.81) in 2 transactions, worth $35.2K in total between Nov 4, 2026 and Nov 5, 2026. Shares held after the trade: 108,701 (+5.6%).

Value
$35.2K
Shares
9,250
Average price
$3.81
Role
Director
Holding change
+5.6%
Trade date
Nov 4, 2026 to Nov 5, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.